ConcertAI, a leading oncology real-world evidence data and AI SaaS technology company, and Foundation Medicine, a global, patient-focused precision medicine company, today announced a collaboration to ...
BOSTON--(BUSINESS WIRE)--Foundation Medicine, Inc. today announced it has awarded two grants to organizations working to address disparities in biomarker testing for breast and prostate cancer ...
BOSTON--(BUSINESS WIRE)--Foundation Medicine, Inc., a genomics company committed to transforming cancer care, today announced that it has expanded its immunohistochemistry (IHC) test offerings to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results